Leaflet GNAK 50mg / ml solution for infusion


Indicated for: rehydration; fluid and electrolyte imbalance

Route of administration: infusion

Substance: glucose + sodium chloride + potassium chloride (glucose solution with electrolytes)

ATC: B05BB02 (Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance)

Precautions:
Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

General data about GNAK 50mg / ml

  • Substance: glucose + sodium chloride + potassium chloride
  • Date of last drug list: 01-05-2026
  • Commercial code: W65917002
  • Concentration: 50mg / ml
  • Pharmaceutical form: solution for infusion
  • Packing volume: 1000 ml
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BIEFFE-MEDITAL S.A. - SPANIA
  • Holder: BAXTER HEALTHCARE SRL - ROMANIA
  • Number: 15196/2023/02
  • Shelf life: 3 years